Marie E. Fallon is See remarks at Ginkgo Bioworks Holdings, Inc. (DNA). They have made 9 open-market trades across 1 company since 2022, most recently 2023-05-02.
CIK 0001883686
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNA | 183,010 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2023-05-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNA | SELL | 2023-05-02 | 2023-05-04 | $1.15 | $9K | +2.5% | +35.2% | +67.2% |
| DNA | SELL | 2023-04-03 | 2023-04-05 | $1.27 | $11K | +3.3% | +5.0% | +52.9% |
| DNA | SELL | 2023-03-02 | 2023-03-03 | $1.33 | $10K | -1.5% | -5.9% | +24.4% |
| DNA | SELL | 2023-02-02 | 2023-02-03 | $2.15 | $14K | -12.1% | -34.3% | -41.1% |
| DNA | SELL | 2023-01-04 | 2023-01-06 | $1.56 | $12K | +7.7% | +26.5% | -12.9% |
| DNA | SELL | 2022-12-02 | 2022-12-05 | $1.94 | $12K | -9.4% | -11.7% | -24.4% |
| DNA | SELL | 2022-11-03 | 2022-11-07 | $2.65 | $17K | -10.4% | -27.1% | -18.3% |
| DNA | SELL | 2022-10-06 | 2022-10-07 | $3.25 | $665K | -20.8% | -22.4% | -49.0% |
| DNA | SELL | 2022-10-03 | 2022-10-07 | $3.12 | $8K | -20.8% | -22.4% | -49.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.